• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

聚(ADP - 核糖)聚合酶的抑制会激活ATM,而ATM是后续同源重组修复所必需的。

Inhibition of poly (ADP-ribose) polymerase activates ATM which is required for subsequent homologous recombination repair.

作者信息

Bryant Helen E, Helleday Thomas

机构信息

The Institute for Cancer Studies, University of Sheffield, Medical School, Beech Hill Road, Sheffield S10 2RX, UK.

出版信息

Nucleic Acids Res. 2006 Mar 23;34(6):1685-91. doi: 10.1093/nar/gkl108. Print 2006.

DOI:10.1093/nar/gkl108
PMID:16556909
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1410911/
Abstract

Poly (ADP-ribose) polymerase (PARP-1), ATM and DNA-dependent protein kinase (DNA-PK) are all involved in responding to DNA damage to activate pathways responsible for cellular survival. Here, we demonstrate that PARP-1-/- cells are sensitive to the ATM inhibitor KU55933 and conversely that AT cells are sensitive to the PARP inhibitor 4-amino-1,8-napthalamide. In addition, PARP-1-/- cells are shown to be sensitive to the DNA-PK inhibitor NU7026 and DNA-PKcs or Ku80 defective cells shown to be sensitive to PARP inhibitors. We believe PARP inhibition results in an increase in unresolved spontaneous DNA single-strand breaks (SSBs), which collapse replication forks and trigger homologous recombination repair (HRR). We show that ATM is activated following inhibition of PARP. Furthermore, PARP inhibitor-induced HRR is abolished in ATM, but not DNA-PK, inhibited cells. ATM and DNA-PK inhibition together give the same sensitivity to PARP inhibitors as ATM alone, indicating that ATM functions in the same pathways as DNA-PK for survival at collapsed forks, likely in non-homologous end joining (NHEJ). Altogether, we suggest that ATM is activated by PARP inhibitor-induced collapsed replication forks and may function upstream of HRR in the repair of certain types of double-strand breaks (DSBs).

摘要

聚(ADP - 核糖)聚合酶(PARP - 1)、共济失调毛细血管扩张症突变基因(ATM)和DNA依赖性蛋白激酶(DNA - PK)均参与对DNA损伤的应答,以激活负责细胞存活的信号通路。在此,我们证明PARP - 1基因敲除细胞对ATM抑制剂KU55933敏感,反之,共济失调毛细血管扩张症(AT)细胞对PARP抑制剂4 - 氨基 - 1,8 - 萘二甲酰胺敏感。此外,PARP - 1基因敲除细胞对DNA - PK抑制剂NU7026敏感,而DNA - PK催化亚基(DNA - PKcs)或Ku80缺陷细胞对PARP抑制剂敏感。我们认为PARP抑制会导致未解决的自发DNA单链断裂(SSB)增加,从而使复制叉坍塌并触发同源重组修复(HRR)。我们发现抑制PARP后ATM被激活。此外,在ATM抑制的细胞中,PARP抑制剂诱导的HRR被消除,但在DNA - PK抑制的细胞中未被消除。同时抑制ATM和DNA - PK对PARP抑制剂的敏感性与单独抑制ATM相同,这表明在复制叉坍塌时,ATM与DNA - PK在相同的信号通路中发挥作用,可能是在非同源末端连接(NHEJ)过程中。总之,我们认为ATM被PARP抑制剂诱导的坍塌复制叉激活,并且可能在某些类型的双链断裂(DSB)修复中在HRR的上游发挥作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b3ad/1410911/9aeeadc1063f/gkl108f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b3ad/1410911/c1ba8149d0c2/gkl108f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b3ad/1410911/413bfb4ec81c/gkl108f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b3ad/1410911/aeed633800c5/gkl108f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b3ad/1410911/fd5409d2c283/gkl108f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b3ad/1410911/d4bb8ccec0d4/gkl108f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b3ad/1410911/4cac4f528bb4/gkl108f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b3ad/1410911/9aeeadc1063f/gkl108f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b3ad/1410911/c1ba8149d0c2/gkl108f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b3ad/1410911/413bfb4ec81c/gkl108f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b3ad/1410911/aeed633800c5/gkl108f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b3ad/1410911/fd5409d2c283/gkl108f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b3ad/1410911/d4bb8ccec0d4/gkl108f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b3ad/1410911/4cac4f528bb4/gkl108f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b3ad/1410911/9aeeadc1063f/gkl108f7.jpg

相似文献

1
Inhibition of poly (ADP-ribose) polymerase activates ATM which is required for subsequent homologous recombination repair.聚(ADP - 核糖)聚合酶的抑制会激活ATM,而ATM是后续同源重组修复所必需的。
Nucleic Acids Res. 2006 Mar 23;34(6):1685-91. doi: 10.1093/nar/gkl108. Print 2006.
2
Role of autophagy in chemoresistance: regulation of the ATM-mediated DNA-damage signaling pathway through activation of DNA-PKcs and PARP-1.自噬在化疗耐药中的作用:通过激活 DNA-PKcs 和 PARP-1 来调节 ATM 介导的 DNA 损伤信号通路。
Biochem Pharmacol. 2012 Mar 15;83(6):747-57. doi: 10.1016/j.bcp.2011.12.029. Epub 2011 Dec 29.
3
Requirement for NBS1 in the S phase checkpoint response to DNA methylation combined with PARP inhibition.NBS1 在 DNA 甲基化联合 PARP 抑制的 S 期检查点反应中的需求。
DNA Repair (Amst). 2011 Feb 7;10(2):225-34. doi: 10.1016/j.dnarep.2010.11.003. Epub 2010 Dec 3.
4
Interaction between ATM and PARP-1 in response to DNA damage and sensitization of ATM deficient cells through PARP inhibition.DNA损伤反应中ATM与PARP-1之间的相互作用以及通过PARP抑制使ATM缺陷细胞致敏。
BMC Mol Biol. 2007 Apr 25;8:29. doi: 10.1186/1471-2199-8-29.
5
Inhibition of poly(ADP-ribose) polymerase (PARP) and ataxia telangiectasia mutated (ATM) on the chemosensitivity of mantle cell lymphoma to agents that induce DNA strand breaks.抑制多聚(ADP-核糖)聚合酶(PARP)和共济失调毛细血管扩张突变(ATM)可提高套细胞淋巴瘤对诱导 DNA 链断裂药物的敏感性。
Hematol Oncol. 2012 Dec;30(4):175-9. doi: 10.1002/hon.1020. Epub 2011 Dec 14.
6
Alkylation DNA damage in combination with PARP inhibition results in formation of S-phase-dependent double-strand breaks.烷化 DNA 损伤与 PARP 抑制相结合会导致 S 期依赖性双链断裂的形成。
DNA Repair (Amst). 2010 Aug 5;9(8):929-36. doi: 10.1016/j.dnarep.2010.05.007. Epub 2010 Jun 22.
7
PARP inhibition during alkylation-induced genotoxic stress signals a cell cycle checkpoint response mediated by ATM.在烷基化诱导的基因毒性应激期间,PARP抑制表明由ATM介导的细胞周期检查点反应。
DNA Repair (Amst). 2009 Nov 2;8(11):1264-72. doi: 10.1016/j.dnarep.2009.07.010. Epub 2009 Aug 31.
8
DNA damage sensors ATM, ATR, DNA-PKcs, and PARP-1 are dispensable for human immunodeficiency virus type 1 integration.DNA损伤传感器ATM、ATR、DNA-PKcs和PARP-1对于1型人类免疫缺陷病毒整合并非必需。
J Virol. 2005 Mar;79(5):2973-8. doi: 10.1128/JVI.79.5.2973-2978.2005.
9
Extracellular signal-related kinase positively regulates ataxia telangiectasia mutated, homologous recombination repair, and the DNA damage response.细胞外信号调节激酶正向调控共济失调毛细血管扩张症突变基因、同源重组修复及DNA损伤反应。
Cancer Res. 2007 Feb 1;67(3):1046-53. doi: 10.1158/0008-5472.CAN-06-2371.
10
The ATM-Chk2 and ATR-Chk1 pathways in DNA damage signaling and cancer.ATM-Chk2 和 ATR-Chk1 通路在 DNA 损伤信号转导和癌症中的作用。
Adv Cancer Res. 2010;108:73-112. doi: 10.1016/B978-0-12-380888-2.00003-0.

引用本文的文献

1
SETD1A-dependent EME1 transcription drives PARPi sensitivity in HR deficient tumour cells.SET1A 依赖的 EME1 转录驱动 HR 缺陷肿瘤细胞对 PARPi 的敏感性。
Br J Cancer. 2025 May;132(8):690-702. doi: 10.1038/s41416-025-02963-0. Epub 2025 Feb 24.
2
The loss of DNA polymerase epsilon accessory subunits POLE3-POLE4 leads to BRCA1-independent PARP inhibitor sensitivity.DNA 聚合酶 ε 辅助亚基 POLE3-POLE4 的缺失导致了不依赖 BRCA1 的 PARP 抑制剂敏感性。
Nucleic Acids Res. 2024 Jul 8;52(12):6994-7011. doi: 10.1093/nar/gkae439.
3
Tumor biomarkers for diagnosis, prognosis and targeted therapy.

本文引用的文献

1
Assessment of ATM phosphorylation on Ser-1981 induced by DNA topoisomerase I and II inhibitors in relation to Ser-139-histone H2AX phosphorylation, cell cycle phase, and apoptosis.评估DNA拓扑异构酶I和II抑制剂诱导的Ser-1981位点ATM磷酸化与Ser-139位点组蛋白H2AX磷酸化、细胞周期阶段及细胞凋亡的关系。
Cytometry A. 2005 Nov;68(1):1-9. doi: 10.1002/cyto.a.20186.
2
Poly(ADP-ribose) polymerase-1 inhibition reverses temozolomide resistance in a DNA mismatch repair-deficient malignant glioma xenograft.聚(ADP - 核糖)聚合酶 -1抑制作用可逆转DNA错配修复缺陷型恶性胶质瘤异种移植模型中的替莫唑胺耐药性。
Mol Cancer Ther. 2005 Sep;4(9):1364-8. doi: 10.1158/1535-7163.MCT-05-0128.
3
肿瘤标志物用于诊断、预后和靶向治疗。
Signal Transduct Target Ther. 2024 May 20;9(1):132. doi: 10.1038/s41392-024-01823-2.
4
Modulating DNA damage response in uveal melanoma through embryonic stem cell microenvironment.通过胚胎干细胞微环境调节葡萄膜黑色素瘤中的DNA损伤反应。
BMC Cancer. 2024 Apr 24;24(1):519. doi: 10.1186/s12885-024-12290-x.
5
A novel targeted NGS panel identifies numerous homologous recombination deficiency (HRD)-associated gene mutations in addition to known BRCA mutations.一种新型靶向 NGS 面板除了已知的 BRCA 突变外,还能鉴定出许多同源重组缺陷(HRD)相关基因突变。
Diagn Pathol. 2024 Jan 6;19(1):9. doi: 10.1186/s13000-023-01431-8.
6
Parp Inhibitors and Radiotherapy: A New Combination for Prostate Cancer (Systematic Review).聚腺苷二磷酸核糖聚合酶抑制剂与放射治疗联合用于前列腺癌的新方案(系统评价)。
Int J Mol Sci. 2023 Aug 19;24(16):12978. doi: 10.3390/ijms241612978.
7
Advances in molecular targeted therapies to increase efficacy of (chemo)radiation therapy.分子靶向治疗在提高(放)化疗疗效中的进展。
Strahlenther Onkol. 2023 Dec;199(12):1091-1109. doi: 10.1007/s00066-023-02064-y. Epub 2023 Apr 11.
8
ATM depletion induces proteasomal degradation of FANCD2 and sensitizes neuroblastoma cells to PARP inhibitors.ATM 耗竭诱导 FANCD2 的蛋白酶体降解,并使神经母细胞瘤细胞对 PARP 抑制剂敏感。
BMC Cancer. 2023 Apr 5;23(1):313. doi: 10.1186/s12885-023-10772-y.
9
High-throughput screen to identify compounds that prevent or target telomere loss in human cancer cells.高通量筛选以鉴定可预防或靶向人类癌细胞中端粒丢失的化合物。
NAR Cancer. 2022 Oct 3;4(4):zcac029. doi: 10.1093/narcan/zcac029. eCollection 2022 Dec.
10
The PARP1 Inhibitor Niraparib Represses DNA Damage Repair and Synergizes with Temozolomide for Antimyeloma Effects.聚(ADP-核糖)聚合酶1抑制剂尼拉帕利可抑制DNA损伤修复,并与替莫唑胺协同发挥抗骨髓瘤作用。
J Oncol. 2022 Apr 5;2022:2800488. doi: 10.1155/2022/2800488. eCollection 2022.
Spontaneous homologous recombination is induced by collapsed replication forks that are caused by endogenous DNA single-strand breaks.
自发同源重组由内源性DNA单链断裂导致的复制叉塌陷所诱导。
Mol Cell Biol. 2005 Aug;25(16):7158-69. doi: 10.1128/MCB.25.16.7158-7169.2005.
4
Mutations in the ATM gene lead to impaired overall and treatment-free survival that is independent of IGVH mutation status in patients with B-CLL.ATM基因的突变会导致B细胞慢性淋巴细胞白血病患者的总生存期和无治疗生存期受损,且这一情况与IGVH突变状态无关。
Blood. 2005 Nov 1;106(9):3175-82. doi: 10.1182/blood-2004-11-4516. Epub 2005 Jul 12.
5
The Artemis:DNA-PKcs endonuclease cleaves DNA loops, flaps, and gaps.阿耳忒弥斯:DNA依赖蛋白激酶催化亚基核酸内切酶可切割DNA环、侧翼序列和缺口。
DNA Repair (Amst). 2005 Jul 12;4(7):845-51. doi: 10.1016/j.dnarep.2005.04.013.
6
PARP inhibitors for cancer therapy.用于癌症治疗的聚(ADP-核糖)聚合酶抑制剂
Expert Rev Mol Med. 2005 Mar 15;7(4):1-20. doi: 10.1017/S146239940500904X.
7
Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy.将BRCA突变细胞中的DNA修复缺陷作为一种治疗策略。
Nature. 2005 Apr 14;434(7035):917-21. doi: 10.1038/nature03445.
8
Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase.用聚(ADP - 核糖)聚合酶抑制剂特异性杀伤BRCA2缺陷型肿瘤
Nature. 2005 Apr 14;434(7035):913-7. doi: 10.1038/nature03443.
9
Identification and characterization of a novel and specific inhibitor of the ataxia-telangiectasia mutated kinase ATM.共济失调毛细血管扩张症突变激酶ATM新型特异性抑制剂的鉴定与表征
Cancer Res. 2004 Dec 15;64(24):9152-9. doi: 10.1158/0008-5472.CAN-04-2727.
10
A pathway of double-strand break rejoining dependent upon ATM, Artemis, and proteins locating to gamma-H2AX foci.一条依赖于ATM、Artemis以及定位于γ-H2AX病灶的蛋白质的双链断裂重新连接途径。
Mol Cell. 2004 Dec 3;16(5):715-24. doi: 10.1016/j.molcel.2004.10.029.